Stock 0A6B DUPONT DE NEMOURS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings DuPont de Nemours, Inc. London S.E.

Equities

0A6B

US26614N1028

Market Closed - London S.E.
Other stock markets
 10:15:34 2024-06-07 EDT 		5-day change 1st Jan Change
79.63 USD +0.00% Intraday chart for DuPont de Nemours, Inc. -0.15% +3.75%
06-13 DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo CI
06-07 Declaration of Voting Results by DuPont de Nemours, Inc CI

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past twelve months, EPS forecast has been revised upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Analyst opinion has improved significantly over the past four months.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The firm trades with high earnings multiples: 30.43 times its 2024 earnings per share.
  • With an enterprise value anticipated at 3.16 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+3.75% 33.38B -
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+2.70% 75.71B
B
BASF SE Stock BASF SE
-7.44% 43.05B
A-
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+15.81% 19.13B
B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+9.79% 11.6B
A-
BRENNTAG SE Stock Brenntag SE
-22.76% 9.92B
B
SYENSQO SA/NV Stock Syensqo SA/NV
-6.51% 9.91B -
SRF LIMITED Stock SRF Limited
-0.78% 8.73B
C-
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-4.14% 8.65B
A-
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
-0.29% 7.68B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DD Stock
  4. 0A6B Stock
  5. Ratings DuPont de Nemours, Inc.